Profilo
Mr. Steven Tuch is a Managing Director & Co-Head of Healthcare Equity Capital Markets at Mizuho Securities USA LLC.
Mr. Tuch was previously employed as a Chief Financial Officer & Executive Vice President by vTv Therapeutics, Inc. and a Head-Corporate Development by Rallybio Corp.
He received his undergraduate degree from the University of Michigan and an MBA from Stanford Graduate School of Business.
Posizioni attive di Steven Tuch
| Società | Posizione | Inizio |
|---|---|---|
Mizuho Securities USA LLC
Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Direttore della Ricerca - Azioni | 01/03/2025 |
Precedenti posizioni note di Steven Tuch
| Società | Posizione | Fine |
|---|---|---|
| VTV THERAPEUTICS INC. | Direttore Finanziario/CFO | 21/03/2025 |
| RALLYBIO CORPORATION | Corporate Officer/Principal | 01/01/2022 |
Formazione di Steven Tuch
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Mizuho Securities USA LLC
Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
















